company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,167262000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,6013000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,173275000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,173275000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6684000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5724000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,182000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,108997000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,121587000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51688000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3840000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3840000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47848000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17884000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29964000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29964000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,157000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29807000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45911000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46357000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45900000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Core Laboratories NV,CLB,,0001000229,2009.0,Q2,2009-04-01,2009-06-30,2010-07-23 19:07:20+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.05
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,167802000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1232000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,169034000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,169034000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6637000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5840000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,183000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,112175000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,124835000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44199000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3895000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3895000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40304000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9189000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31115000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31115000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,127000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30988000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45939000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.67
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46499000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46300000.0
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.67
Core Laboratories NV,CLB,,0001000229,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 17:10:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.43
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,188337000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,798000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,189135000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,189135000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6380000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5419000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,335000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,125588000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,137722000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51413000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4059000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4059000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47354000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15068000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32286000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32286000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,81000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32205000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44836000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46820000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44700000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Core Laboratories NV,CLB,,0001000229,2010.0,Q1,2010-01-01,2010-03-31,2011-04-22 11:42:51+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.06
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,198902000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,198902000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,198902000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9211000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5430000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,336000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,130205000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,145182000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53720000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4114000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4114000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49606000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15244000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34362000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,34362000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,146000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34216000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44651000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47957000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44400000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
Core Laboratories NV,CLB,,0001000229,2010.0,Q2,2010-04-01,2010-06-30,2011-07-29 17:20:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.06
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,199221000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,199221000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,199221000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8416000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5496000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,318000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,124774000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,139004000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60217000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4690000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4690000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,55527000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16764000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38763000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38763000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,209000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38554000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44736000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48955000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44800000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
Core Laboratories NV,CLB,,0001000229,2010.0,Q3,2010-07-01,2010-09-30,2011-10-25 17:26:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.71
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,208193000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-798000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,207395000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,513790000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,513790000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-306395000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9022000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5475000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,304000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-382772000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-367971000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61576000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4915000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4915000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,56661000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16671000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39990000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39990000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,48000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39942000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44830000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48241000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.89
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Core Laboratories NV,CLB,,0001000229,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.06
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,206733000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,206733000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,206733000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9524000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5540000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,134879000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,150234000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56499000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2989000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2989000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53510000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7518000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45992000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45992000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-298000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46290000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45225000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.02
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49141000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45400000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.02
Core Laboratories NV,CLB,,0001000229,2011.0,Q1,2011-01-01,2011-03-31,2012-04-23 16:09:24+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.25
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,225785000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,225785000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,225785000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9757000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5507000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,298000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,152420000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,167982000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,57803000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2709000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2709000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,55094000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14710000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40384000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40384000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-67000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,40451000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,0.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45945000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48662000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,0.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Core Laboratories NV,CLB,,0001000229,2011.0,Q2,2011-04-01,2011-06-30,2012-07-20 16:06:20+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.25
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,231344000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,231344000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,231344000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11182000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5460000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,278000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,150860000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,167780000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63564000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3856000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3856000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59708000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14599000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45109000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45109000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,242000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44867000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46606000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.96
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48030000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46700000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.96
Core Laboratories NV,CLB,,0001000229,2011.0,Q3,2011-07-01,2011-09-30,2012-10-19 16:08:43+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.25
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,243786000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,243786000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,593369000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,593369000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-349583000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10678000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5619000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,310000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-439078000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-422471000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,72888000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2358000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2358000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,70530000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17371000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53159000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,53159000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,83000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-40451000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93527000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46286000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48393000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.02
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46300000.0
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
Core Laboratories NV,CLB,,0001000229,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.25
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,234191000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,234191000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,149140000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,149140000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85051000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10174000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5596000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,287000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4912000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11145000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73906000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2190000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2190000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,71716000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17786000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,53930000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,53930000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-21000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,53951000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47606000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.13
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47945000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.13
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47700000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.13
Core Laboratories NV,CLB,,0001000229,2012.0,Q1,2012-01-01,2012-03-31,2013-04-19 16:07:43+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,247006000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,247006000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,156380000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,156380000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90626000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10205000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,4788000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,289000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3218000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18500000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,72126000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2178000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2178000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,69948000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16997000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52951000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52951000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,35000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52916000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47473000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47791000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.11
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47700000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Core Laboratories NV,CLB,,0001000229,2012.0,Q2,2012-04-01,2012-06-30,2013-07-19 16:06:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,245428000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,245428000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,155341000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,155341000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90087000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10504000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6170000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,289000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2256000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14707000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,75380000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2160000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2160000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73220000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18671000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,54549000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,54549000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,146000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,54403000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47232000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47528000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47300000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
Core Laboratories NV,CLB,,0001000229,2012.0,Q3,2012-07-01,2012-09-30,2013-10-18 16:04:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,254455000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,254455000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,160958000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,160958000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93497000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12302000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5208000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,290000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-171000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17629000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,75868000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2292000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2292000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,73576000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18394000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55182000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55182000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,381000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,54801000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47211000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.19
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47553000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47200000.0
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.19
Core Laboratories NV,CLB,,0001000229,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,260927000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,260927000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,163645000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,163645000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,97282000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12809000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5723000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,302000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-589000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18245000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,79037000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2269000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2269000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,76768000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20036000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56732000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56732000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,216000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56516000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46201000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.22
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46493000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.22
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46300000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.22
Core Laboratories NV,CLB,,0001000229,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 16:13:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,263139000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,263139000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,163503000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,163503000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99636000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11173000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5656000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,308000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,630000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17767000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,81869000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2263000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2263000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,79606000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19664000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59942000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,59942000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,266000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,59676000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45841000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46128000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.29
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45900000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
Core Laboratories NV,CLB,,0001000229,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 16:05:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,273163000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,273163000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,167427000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,167427000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105736000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14346000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6396000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,357000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,41000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21140000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,84596000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2302000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2302000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,82294000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20490000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61804000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61804000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-91000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61895000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45526000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45828000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45500000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
Core Laboratories NV,CLB,,0001000229,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:06:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,276279000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,276279000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168393000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168393000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,107886000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13660000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6393000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,336000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-420000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20645000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87917000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2483000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2483000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,85434000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20718000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64716000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64716000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-8000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,64724000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45692000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45994000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.42
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45700000.0
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Core Laboratories NV,CLB,,0001000229,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,262903000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,262903000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,161669000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,161669000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,101234000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10519000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6342000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1255000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18407000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,82827000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2363000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2363000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,80464000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19311000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61153000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61153000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,89000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61064000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44908000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45182000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44900000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
Core Laboratories NV,CLB,,0001000229,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:05:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,267562000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,267562000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168158000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168158000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99404000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11148000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6027000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,291000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2196000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15270000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,84134000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2794000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2794000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,81340000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17244000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64096000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64096000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,362000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63734000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44660000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44910000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.42
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44600000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Core Laboratories NV,CLB,,0001000229,2014.0,Q2,2014-04-01,2014-06-30,2015-07-24 18:03:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,276135000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,276135000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,166927000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,166927000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109208000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12316000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6362000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,483000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,927000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20088000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,89120000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2561000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2561000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86559000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19909000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66650000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,66650000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,153000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,66497000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44152000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.51
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44381000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44000000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.51
Core Laboratories NV,CLB,,0001000229,2014.0,Q3,2014-07-01,2014-09-30,2015-10-23 16:05:46+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,278622000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,278622000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,168517000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,168517000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110105000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11672000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6566000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,334000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1083000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19655000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,90450000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2882000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2882000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,87568000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20841000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66727000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,66727000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,537000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,66190000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44362000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44600000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44400000.0
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Core Laboratories NV,CLB,,0001000229,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.5
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,213643000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,213643000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,144274000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,144274000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69369000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12674000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6345000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,221000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,7412000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26652000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42717000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2403000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2403000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40314000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9272000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31042000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31042000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-357000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31399000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43340000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43466000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43600000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Core Laboratories NV,CLB,,0001000229,2015.0,Q1,2015-01-01,2015-03-31,2016-04-22 17:26:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,203889000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,203889000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,134619000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,134619000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69270000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12634000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6752000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,178000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1813000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21377000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47893000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3116000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3116000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,44777000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10075000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34702000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,34702000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,76000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34626000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42790000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42959000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Core Laboratories NV,CLB,,0001000229,2015.0,Q2,2015-04-01,2015-06-30,2016-07-22 16:06:17+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,197265000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,197265000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,129050000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,129050000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,68215000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12155000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6695000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,215000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2332000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21397000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,46818000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3471000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3471000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,43347000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9753000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,190000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33404000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42517000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.79
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42685000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42300000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.79
Core Laboratories NV,CLB,,0001000229,2015.0,Q3,2015-07-01,2015-09-30,2016-10-21 16:06:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,182723000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,182723000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,124709000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,124709000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,58014000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12266000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6753000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,298000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15055000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34372000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,23642000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3390000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3390000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20252000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4658000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15594000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,176000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15418000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42747000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42908000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42700000.0
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Core Laboratories NV,CLB,,0001000229,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,153647000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,153647000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,112814000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,112814000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40833000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11050000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6627000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,220000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17893000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22940000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3434000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3434000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19506000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4389000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15117000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15117000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,35000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15082000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42380000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42520000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41900000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Core Laboratories NV,CLB,,0001000229,2016.0,Q1,2016-01-01,2016-03-31,2017-04-21 16:44:33+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,148069000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,148069000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,109999000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,109999000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38070000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11139000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6531000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,220000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-47000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17843000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20227000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3021000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3021000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17206000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,671000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16535000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16535000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-89000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16624000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43297000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43505000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43700000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Core Laboratories NV,CLB,,0001000229,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:06:22+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,143483000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,143483000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,107153000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,107153000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36330000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8406000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6548000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,176000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-288000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14842000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21488000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2569000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2569000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18919000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2081000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16838000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16838000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,108000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16730000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44110000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44320000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44000000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Core Laboratories NV,CLB,,0001000229,2016.0,Q3,2016-07-01,2016-09-30,2017-10-24 18:35:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,145033000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,145033000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,107537000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,107537000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37496000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8795000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5739000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,227000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-61000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14700000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22796000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2548000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2548000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20248000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3714000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16534000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1165000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15369000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-90000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15459000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43479000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43670000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43500000.0
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Core Laboratories NV,CLB,,0001000229,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,156609000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,156609000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113021000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113021000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,43588000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12756000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,6079000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,225000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,989000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20049000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,23539000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2618000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2618000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20921000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2929000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17992000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-310000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17682000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17658000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44159000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44347000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44100000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Core Laboratories NV,CLB,,0001000229,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:17:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,158212000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,158212000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,113635000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,113635000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44577000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11100000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5979000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,209000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-66000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17222000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27355000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2692000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2692000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24663000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3709000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20954000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1755000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22709000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,19000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22690000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44164000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44374000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44500000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Core Laboratories NV,CLB,,0001000229,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:34:11+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,162887000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,162887000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,118361000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,118361000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44526000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11887000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5743000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,250000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-23000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17857000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26669000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2707000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2707000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23962000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3595000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20367000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,686000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21053000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-33000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21086000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44141000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44332000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43900000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Core Laboratories NV,CLB,,0001000229,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 17:06:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,170111000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,170111000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,119941000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119941000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50170000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11994000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5804000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,235000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-268000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17765000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32405000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2717000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2717000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29688000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8016000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21672000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-20000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21652000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-39000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21691000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44153000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44264000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Core Laboratories NV,CLB,,0001000229,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,170018000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,170018000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,119318000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119318000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,50700000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12709000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5582000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,236000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-143000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18384000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32316000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3120000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3120000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,29196000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5273000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23923000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-346000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23577000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,50000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23527000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44179000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44463000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44400000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Core Laboratories NV,CLB,,0001000229,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 19:07:14+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,175475000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,175475000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,123773000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,123773000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,51702000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12202000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5628000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,240000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,183000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18253000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33449000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3296000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3296000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30153000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5000000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25133000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-328000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,24805000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,53000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,24752000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44203000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44493000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Core Laboratories NV,CLB,,0001000229,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 20:47:09+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,182146000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,182146000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,128179000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,128179000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,53967000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13278000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5436000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,244000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,34329000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53287000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,680000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3278000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34199000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30921000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,31601000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9404000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22197000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,208000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-22412000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-7000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44216000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44591000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Core Laboratories NV,CLB,,0001000229,2018.0,Q3,2018-07-01,2018-09-30,2019-10-24 19:10:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,173207000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,173207000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,125694000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125694000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,47513000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24721000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5367000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,354000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-35106000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-4664000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52177000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3634000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34199000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-37833000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14344000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5770000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8594000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,408000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,22412000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31414000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,167000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31247000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44206000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44474000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Core Laboratories NV,CLB,,0001000229,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.1
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,169194000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,169194000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,127383000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,127383000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41811000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17437000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5239000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,348000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2373000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25397000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16414000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3726000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3726000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12688000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-27610000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40298000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,259000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40557000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,47000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,40510000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44323000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44734000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44500000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Core Laboratories NV,CLB,,0001000229,2019.0,Q1,2019-01-01,2019-03-31,2020-04-23 19:01:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,169038000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,169038000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,124451000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,124451000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44587000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9801000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,5193000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,593000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,992000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16579000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28008000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3714000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3714000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24294000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4800000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19486000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7971000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27457000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,43000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27414000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44354000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.62
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44815000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44200000.0
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.62
Core Laboratories NV,CLB,,0001000229,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 20:47:09+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.55
